Taiwan · Delayed Price · Currency is TWD GeneFerm Biotechnology Statistics
Total Valuation
TPEX:1796 has a market cap or net worth of TWD 1.86 billion. The enterprise value is 1.91 billion.
| Market Cap | 1.86B |
| Enterprise Value | 1.91B |
Important Dates
The next estimated earnings date is Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:1796 has 41.46 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 41.46M |
| Shares Outstanding | 41.46M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 9.52% |
| Owned by Institutions (%) | n/a |
| Float | 20.67M |
Valuation Ratios
The trailing PE ratio is 115.56.
| PE Ratio | 115.56 |
| Forward PE | n/a |
| PS Ratio | 2.84 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | 21.75 |
| P/OCF Ratio | 17.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.72, with an EV/FCF ratio of 22.36.
| EV / Earnings | 118.81 |
| EV / Sales | 2.92 |
| EV / EBITDA | 19.72 |
| EV / EBIT | 90.30 |
| EV / FCF | 22.36 |
Financial Position
The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.41.
| Current Ratio | 3.87 |
| Quick Ratio | 2.60 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 3.38 |
| Debt / FCF | 3.84 |
| Interest Coverage | 3.59 |
Financial Efficiency
Return on equity (ROE) is 2.03% and return on invested capital (ROIC) is 2.43%.
| Return on Equity (ROE) | 2.03% |
| Return on Assets (ROA) | 1.09% |
| Return on Invested Capital (ROIC) | 2.43% |
| Return on Capital Employed (ROCE) | 1.90% |
| Revenue Per Employee | 4.55M |
| Profits Per Employee | 111,618 |
| Employee Count | 144 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.76 |
Taxes
| Income Tax | -1.96M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.05% in the last 52 weeks. The beta is -0.16, so TPEX:1796's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | +7.05% |
| 50-Day Moving Average | 47.15 |
| 200-Day Moving Average | 48.64 |
| Relative Strength Index (RSI) | 35.57 |
| Average Volume (20 Days) | 25,448 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1796 had revenue of TWD 654.88 million and earned 16.07 million in profits. Earnings per share was 0.39.
| Revenue | 654.88M |
| Gross Profit | 163.23M |
| Operating Income | 21.15M |
| Pretax Income | 14.11M |
| Net Income | 16.07M |
| EBITDA | 89.79M |
| EBIT | 21.15M |
| Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 275.46 million in cash and 327.72 million in debt, with a net cash position of -52.27 million or -1.26 per share.
| Cash & Cash Equivalents | 275.46M |
| Total Debt | 327.72M |
| Net Cash | -52.27M |
| Net Cash Per Share | -1.26 |
| Equity (Book Value) | 800.39M |
| Book Value Per Share | 19.31 |
| Working Capital | 421.89M |
Cash Flow
In the last 12 months, operating cash flow was 105.40 million and capital expenditures -20.00 million, giving a free cash flow of 85.39 million.
| Operating Cash Flow | 105.40M |
| Capital Expenditures | -20.00M |
| Free Cash Flow | 85.39M |
| FCF Per Share | 2.06 |
Margins
Gross margin is 24.92%, with operating and profit margins of 3.23% and 2.45%.
| Gross Margin | 24.92% |
| Operating Margin | 3.23% |
| Pretax Margin | 2.15% |
| Profit Margin | 2.45% |
| EBITDA Margin | 13.71% |
| EBIT Margin | 3.23% |
| FCF Margin | 13.04% |
Dividends & Yields
TPEX:1796 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 0.87% |
| FCF Yield | 4.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:1796 has an Altman Z-Score of 3.77 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.77 |
| Piotroski F-Score | 7 |